Abstract
In the aging population of the USA, the burden of aortic valve disease continues to be a major contributor to mortality and morbidity, affecting millions of patients annually. While traditional surgical management has produced excellent results, many elderly patients are not good surgical candidates for invasive procedures. Recently, considerable effort has been placed in developing less invasive approaches that will benefit the elderly. Currently, a wide range of minimally invasive technologies exist at the surgeon’s disposal, including percutaneous and transcatheter-based devices. In this review, we examine the current gold-standard therapies and outcomes, as well as the exciting approaches that are being tested. Finally, we address the future direction in management of aortic valve disease in the elderly and its impact on clinical practice.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
